NCT07197554 2026-02-18
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
SEED Therapeutics, Inc.
Phase 1 Recruiting
SEED Therapeutics, Inc.
Taiho Pharmaceutical Co., Ltd.
Mannkind Corporation